[Drug interactions in therapy of cardiac decompensation].
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D004077:Digoxin / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004347:Drug Interactions; D006333:Heart Failure / Q000188:drug therapy*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D013442:Sulfinpyrazone / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D000925:Anticoagulants; D004232:Diuretics; D006635:Histamine H2 Antagonists; D004077:Digoxin; D001241:Aspirin; D013442:Sulfinpyrazone
Interazioni farmacologiche nella terapia dello scompenso cardiaco.